Aurobindo Pharma gets USFDA nod for oral suspension
Sevelamer Carbonate oral suspension is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Chronic Kidney Disease | Dialysis | Pharmaceuticals | Renvela | Urology & Nephrology